When I think of what large drugs PFE came out with over the past decade I come up with Sutent (purchased), Chantix (mistake) and Lyrica. Those drugs aren't worth $50 billion.
What does the $50B figure refer to? There’s no argument that PFE’s R&D has produced poor results in the past decade, but does it necessarily follow that outsourcing basic research from here on will lead to an improvement? Perhaps a better fix is to hire smarter scientists (#msg-16127025).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”